Angiex, Inc.

150 Cambridge Park Drive, 5th Floor, CAMBRIDGE, MA, 02140 · 857-203-7808

Biotechnology · Corporation· inc. DELAWARE true

Fit score

—

Offering

$28.4M

Sold

$22.0M

% sold

77.4%

Investors

137

Min investment

Exemption

506(c)

Filing history

Filed	Form	Rule	Offering	Sold	% sold	Investors
2025-09-26	D/A ·current	506(c)	$28.4M	$22.0M	77.4%	137	EDGAR ↗
2025-08-14	D	506(c)	$20.3M	$11.0M	54.1%	57	EDGAR ↗

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Paul Jaminet — Executive Officer / Director, Cambridge, MA
Amal Amin — Director, Cambridge, MA
Jason Camm — Director, Cambridge, MA
1 other raise
- Alloy Therapeutics, Inc. $30.0M of $40.0M · 75.1%
Haijing Guo — Director, Cambridge, MA
Fabian Hansen — Director, Cambridge, MA
Tina Neel — Director, Cambridge, MA
Jonathan Adams — Director, Cambridge, MA
1 other raise
- Rival Holdings LLC / PA $2.9M of $4.0M · 73.0%
Iain Dukes — Director, Cambridge, MA
1 other raise
- Ikena Oncology, Inc. $0 of $75.0M · 0.0%
Errik Anderson — Director, Cambridge, MA
3 other raises
- Alumni Ventures Group LLC $27.4M of $36.0M · 76.0%
- Cantai Therapeutics, Inc. $3.0M of $3.0M · 100.0%
- 82VS Seed Fund, LP $20.0M of $20.0M · 100.0%

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.